Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

07/05/2014 The new Hewlett-Packard world development center for 3D printers will be in Barcelona 28/04/2014 Loss of memory reversed in Alzheimer's mice models 25/04/2014 More than 30 companies attended the ALBA industry workshop 15/04/2014 European Commission names Barcelona first European Capital of Innovation 11/04/2014 Visit of the Spanish State Secretary for research to the Barcelona Synchrotron Park (BSP) 02/04/2014 High-precision molding in the PTV
41 42 43 44 45 46 47 48 49